Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Pharmaron Beijing Co., Ltd.*

康龍化成(北京)新藥技術 股份有限公 司

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code:3759)

NOTICE OF THE ANNUAL GENERAL MEETING OF 2020

NOTICE IS HEREBY GIVEN THAT the Annual General Meeting of 2020 (the "AGM") of Pharmaron Beijing Co., Ltd.* (康龍化成(北京)新藥技術股份有限公司) (the "Company") will be held at 6 Tai-He Road, Economic Technological Development Area, Beijing, the PRC on Friday, May 28, 2021 at 2 p.m. for the following purposes:

ORDINARY RESOLUTIONS

  1. Work Report of the Board of Directors for the year 2020.
  2. Work Report of the Supervisory Committee for the year 2020.
  3. Financial Statements for the year 2020.
  4. 2020 Profit Distribution Plan.
  5. 2020 Annual Report's full text and report summary and 2020 Annual Results Announcement.
  6. Remuneration of the Directors for the year 2021.
  7. Remuneration of the Supervisors for the year 2021.
  8. Engagement of Domestic Auditor for the year 2021.
  9. Engagement of International Auditor for the year 2021.
  10. Guarantees Quota for the year 2021.
  11. Foreign Exchange Hedging Quota for the year 2021.

15. Authorization for Registration of the Reduction in Registered Capital and Amendments to the Articles of Association.

- 1 -

SPECIAL RESOLUTIONS

  1. Repurchase and Cancellation of Part of the Restricted A Shares Granted Under the A Share Incentive Scheme.
  2. Reduction of Registered Capital.
  3. Amendments to the Articles of Association

16. Granting of General Mandate to Issue A Shares and/or H Shares.

By order of the Board

Pharmaron Beijing Co., Ltd.*

康龍化成(北京)新藥技術股份有限公司

Dr. Lou Boliang

Chairman

Beijing, the PRC

April 28, 2021

As at the date of this announcement, the Board of Directors comprises Dr. Lou Boliang, Mr. Lou Xiaoqiang and Ms. Zheng Bei as executive Directors; Mr. Chen Pingjin, Mr. Hu Baifeng, Mr. Li Jiaqing and Mr. Zhou Hongbin as non-executive Directors; Mr. Dai Lixin, Ms. Chen Guoqin, Mr. Tsang Kwan Hung Benson and Mr. Yu Jian as independent non-executive Directors.

Notes:

  1. The register of members of the Company will be closed for the purpose of determining Shareholders' entitlement to attend the AGM from Tuesday, May 25, 2021 to Friday, May 28, 2021 (both days inclusive), during which period no transfer of Shares will be registered. In order to attend the AGM, H Shareholders should ensure that all transfer documents, accompanied by the relevant share certificates, are lodged with the Company's H Share registrar, Computershare Hong Kong Investor Services Limited, at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong (for H Shareholders) no later than 4:30 p.m. on Monday, May 24, 2021 to complete registration. The H shareholders listed on the register of the Company on Tuesday, May 25, 2021 shall have the right to attend and vote at the Annual General Meeting.
  2. Subject to the approval of the resolution regarding the declaration of dividends at the AGM for 2020, dividends will be paid to the Shareholders whose names appear on the register of members of the Company after the close of the market on Tuesday, June 8, 2021. The register of members of the Company will be closed from Thursday, June 3, 2021 to Tuesday, June 8, 2021 (both days inclusive), during which period no transfer of shares will be registered. In order for the holders of H Shares of the Company to qualify for receiving the final dividends, but no transfer documents have been registered, all completed share transfer documents accompanied by the relevant share certificates must be lodged with the Company's H Share registrar in Hong Kong, Computershare Hong Kong Investor Services Limited, at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong on or before Wednesday, June 2, 2021 at 4:30 p.m.
  3. The Company shall duly dispatch and publish the circular, reply slip and form of proxy of shareholders of the AGM. Any shareholder of the Company ("Shareholder") who intends to appoint a proxy shall refer to the 2020 Annual Report of the Company which were published on the website of The Stock Exchange of Hong Kong Limited ("Hong Kong Stock Exchange") and the Company's website and dispatched to the relevant shareholders. The 2020 Annual Report included Directors' Report for 2020, audited Financial Statements and Auditor's Report for 2020.

- 2 -

  1. All votes of resolutions at the Annual General Meeting will be taken by poll pursuant to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and the results of the poll will be published on the websites of The Stock Exchange of Hong Kong Limited (www.hkexnews.hk) and the Company (www.pharmaron.com) in accordance with the Listing Rules.
  2. Any shareholders entitled to attend and vote at the AGM can appoint one or more proxies to attend and vote at the AGM on his/her behalf. A proxy need not be a shareholder of the Company. If more than one proxy is so appointed, the appointment shall specify the number and type of shares in respect of which each proxy is so appointed.
  3. Shareholders shall appoint their proxies in writing. The form of proxy shall be signed by the shareholder or his/her/its attorney who has been authorized in writing. If the shareholder is a corporation, the form of proxy shall be affixed with the corporation's seal or signed by its director, or its attorney duly authorized in writing. If the form of proxy is signed by the attorney of the shareholder, the power of attorney or other authorization document shall be notarized. For H Shareholders, the aforementioned documents must be lodged with the H Shares Registrar, Computershare Hong Kong Investor Services Limited, at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong not less than 24 hours before the time appointed for holding the AGM or any adjournment thereof (i.e. 2 p.m. on Thursday, May 27, 2021 (Hong Kong time)) in order for such documents to be valid. Completion and delivery of the form of proxy shall not preclude a shareholder of the Company from attending and voting in person at the meeting and, in such event, the instrument appointing a proxy shall be deemed to be revoked.
  4. Shareholders who intend to attend the AGM (in person or by proxy) shall deliver the reply slip of AGM to the H Shares Registrar of the Company, Computershare Hong Kong Investor Services Limited, at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong by hand or by post on or before Monday, May 24, 2021.
  5. Shareholders shall produce their identification documents when attending the AGM.
  6. If a proxy attends the AGM on behalf of a shareholder, he/she should produce his/her identification document and the power of attorney or other documents signed by the appointer or his/her attorney, which specifies the date of its issuance. If a representative of a corporate shareholder attends the AGM, such representative shall produce his/her identification document and the notarized copy of the resolution passed by the board of directors or other authority or notarized copy of any authorization documents issued by such corporate shareholder.
  7. The AGM is expected to last for half a day. Shareholders who attend the AGM (in person or by proxy) shall bear their own traveling, accommodation and other expenses.
  8. The contact of the Company:
    Address: Pharmaron Beijing Co., Ltd.* (康龍化成(北京)新藥技術股份有限公司)
    6 Tai-He Road, Economic Technological Development Area, Beijing, the PRC
    Postal Code: 100176
    Tel: 86 010-57330087
    Contact Person: LI Shing Chung Gilbert
    Fax: 86 010-57330087

* For identification purposes only

- 3 -

Attachments

  • Original document
  • Permalink

Disclaimer

Pharmaron Beijing Co. Ltd. published this content on 28 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 April 2021 09:54:04 UTC.